Hos diabetikere der behandles peroralt med antidiabetika eller insulin, bør den glycæmiske kontrol monitoreres nøje den første måned af ACE- hæmmer behandlingen (se punkt 4. 5).
In diabetic patients treated with oral antidiabetic agents or insulin, glycaemic control should be closely monitored during the first month of treatment with an ACE inhibitor (see section 4.5)